1887

Abstract

Diabetic foot infection (DFI) is the main reason for diabetes-related hospitalisation and is a major cause of diabetes-related amputation. DFIs are often complicated by ischaemia in the affected limb, the presence of polymicrobial biofilms and increasingly the occurrence of antibiotic resistant bacteria.

Antibiotic loaded beads could inhibit the growth of polymicrobial DFI communities with differing compositions .

This study investigates the efficacy of antibiotic loaded calcium sulfate beads (Stimulan Rapid Cure, Biocomposites Ltd., UK) against polymicrobial DFI communities and individual bacterial strains derived from DFIs.

Debrided tissue obtained from the base of infected diabetic foot ulcers was homogenised and spread over the surface of Columbia blood agar (CBA) and fastidious anaerobe agar (FAA) plates. Calcium sulfate beads containing a combination of vancomycin and gentamicin were then placed on the surface of the agar and following incubation, zones of inhibition (ZOI) were measured. For individual bacterial strains isolated from the infected tissue, calcium sulfate beads containing vancomycin, gentamicin, flucloxacillin or rifampicin and beads containing a combination of vancomycin and gentamicin or flucloxacillin and rifampicin were tested for their ability to inhibit growth.

Calcium sulfate beads loaded with a combination of vancomycin and gentamicin were able to inhibit bacterial growth from all polymicrobial tissue homogenates tested, with ZOI diameters ranging from 15 to 40 mm. In the case of individual bacterial strains, beads containing combinations of vancomycin and gentamicin or flucloxacillin and rifampicin were able to produce ZOI with Gram-positive facultatitive anaerobic strains such as and , Gram-negative facultative anaerobic strains such as and obligate anaerobic strains such as even where acquired resistance to one of the antibiotics in the combination was evidenced.

The local use of calcium sulfate beads containing a combination of two antibiotics demonstrated high efficacy against polymicrobial DFI communities and individual DFI bacterial strains in zone of inhibition tests. These results show promise for clinical application, but further research and clinical studies are required.

  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001517
2022-05-23
2024-05-14
Loading full text...

Full text loading...

/deliver/fulltext/jmm/71/5/jmm001517.html?itemId=/content/journal/jmm/10.1099/jmm.0.001517&mimeType=html&fmt=ahah

References

  1. World Health Organisation Global report on diabetes [Internet]; 2016 www.who.int/publications-detail/global-report-on-diabetes
  2. Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 2017; 128:40–50 [View Article] [PubMed]
    [Google Scholar]
  3. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA 2005; 293:217–228 [View Article] [PubMed]
    [Google Scholar]
  4. McIntosh C, Ivory JD, Gethin G, MacGilchrist C. Optimising wellbeing in patients with diabetic foot ulcers. J EWMA (JEWMA) 2019; 20:23–28 [View Article]
    [Google Scholar]
  5. Ndosi M, Wright-Hughes A, Brown S, Backhouse M, Lipsky BA et al. Prognosis of the infected diabetic foot ulcer: a 12-month prospective observational study. Diabet Med 2018; 35:78–88 [View Article] [PubMed]
    [Google Scholar]
  6. Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med 2017; 376:2367–2375 [View Article] [PubMed]
    [Google Scholar]
  7. Lipsky BA, Senneville É, Abbas ZG, Aragón‐Sánchez J, Diggle M et al. Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev 2020; 36:S1 [View Article]
    [Google Scholar]
  8. Ertuğrul B, Uçkay I, Schöni M, Peter-Riesch B, Lipsky BA. Management of diabetic foot infections in the light of recent literature and new international guidelines. Expert Rev Anti Infect Ther 2020; 18:293–305 [View Article] [PubMed]
    [Google Scholar]
  9. Kerr M, Barron E, Chadwick P, Evans T, Kong WM et al. The cost of diabetic foot ulcers and amputations to the National Health Service in England. Diabet Med 2019; 36:995–1002 [View Article] [PubMed]
    [Google Scholar]
  10. Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJG et al. 2012 infectious diseases society of america clinical practice guideline for the diagnosis and treatment of diabetic foot infectionsa. Clin Infect Dis 2012; 54:e132–e173 [View Article]
    [Google Scholar]
  11. Lipsky BA, Aragón-Sánchez J, Diggle M, Embil J, Kono S et al. IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes. Diabetes Metab Res Rev 2016; 32 Suppl 1:45–74 [View Article] [PubMed]
    [Google Scholar]
  12. Mills JL. Lower limb ischaemia in patients with diabetic foot ulcers and gangrene: recognition, anatomic patterns and revascularization strategies. Diabetes Metab Res Rev 2016; 32 Suppl 1:239–245 [View Article] [PubMed]
    [Google Scholar]
  13. Andersson DI, Hughes D. Microbiological effects of sublethal levels of antibiotics. Nat Rev Microbiol 2014; 12:465–478 [View Article] [PubMed]
    [Google Scholar]
  14. Oates A, Bowling FL, Boulton AJM, Bowler PG, Metcalf DG et al. The visualization of biofilms in chronic diabetic foot wounds using routine diagnostic microscopy methods. J Diabetes Res 2014; 2014:153586 [View Article] [PubMed]
    [Google Scholar]
  15. Johani K, Malone M, Jensen S, Gosbell I, Dickson H et al. Microscopy visualisation confirms multi-species biofilms are ubiquitous in diabetic foot ulcers. Int Wound J 2017; 14:1160–1169 [View Article] [PubMed]
    [Google Scholar]
  16. Johani K, Fritz BG, Bjarnsholt T, Lipsky BA, Jensen SO et al. Understanding the microbiome of diabetic foot osteomyelitis: insights from molecular and microscopic approaches. Clin Microbiol Infect 2019; 25:332–339 [View Article] [PubMed]
    [Google Scholar]
  17. Flemming HC, Wingender J, Szewzyk U, Steinberg P, Rice SA et al. Biofilms: an emergent form of bacterial life. Nat Rev Microbiol 2016; 14:563–575 [View Article] [PubMed]
    [Google Scholar]
  18. Hurlow JJ, Humphreys GJ, Bowling FL, McBain AJ. Diabetic foot infection: A critical complication. Int Wound J 2018; 15:814–821 [View Article] [PubMed]
    [Google Scholar]
  19. Berberich C, Sanz-Ruiz P. Risk assessment of antibiotic resistance development by antibiotic-loaded bone cements: is it a clinical concern?. EFORT Open Rev 2019; 4:576–584 [View Article] [PubMed]
    [Google Scholar]
  20. Gauland C. Managing lower-extremity osteomyelitis locally with surgical debridement and synthetic calcium sulfate antibiotic tablets. Adv Skin Wound Care 2011; 24:515–523 [View Article] [PubMed]
    [Google Scholar]
  21. Izakovicova P, Borens O, Trampuz A. Periprosthetic joint infection: current concepts and outlook. EFORT Open Rev 2019; 4:482–494 [View Article] [PubMed]
    [Google Scholar]
  22. Laycock PA, Cooper JJ, Howlin RP, Delury C, Aiken S et al. In vitro efficacy of antibiotics released from calcium sulfate bone void filler beads. Materials (Basel) 2018; 11:E2265 [View Article] [PubMed]
    [Google Scholar]
  23. Kluin OS, van der Mei HC, Busscher HJ, Neut D. Biodegradable vs non-biodegradable antibiotic delivery devices in the treatment of osteomyelitis. Expert Opin Drug Deliv 2013; 10:341–351 [View Article] [PubMed]
    [Google Scholar]
  24. Neut D, van de Belt H, Stokroos I, van Horn JR, van der Mei HC et al. Biomaterial-associated infection of gentamicin-loaded PMMA beads in orthopaedic revision surgery. J Antimicrob Chemother 2001; 47:885–891 [View Article] [PubMed]
    [Google Scholar]
  25. Neut D, van de Belt H, van Horn JR, van der Mei HC, Busscher HJ. Residual gentamicin-release from antibiotic-loaded polymethylmethacrylate beads after 5 years of implantation. Biomaterials 2003; 24:1829–1831 [View Article] [PubMed]
    [Google Scholar]
  26. Aiken SS, Cooper JJ, Florance H, Robinson MT, Michell S. Local release of antibiotics for surgical site infection management using high-purity calcium sulfate: an in vitro elution study. Surg Infect (Larchmt) 2015; 16:54–61 [View Article] [PubMed]
    [Google Scholar]
  27. Howlin RP, Brayford MJ, Webb JS, Cooper JJ, Aiken SS et al. Antibiotic-loaded synthetic calcium sulfate beads for prevention of bacterial colonization and biofilm formation in periprosthetic infections. Antimicrob Agents Chemother 2015; 59:111–120 [View Article] [PubMed]
    [Google Scholar]
  28. Howlin RP, Winnard C, Frapwell CJ, Webb JS, Cooper JJ et al. Biofilm prevention of gram-negative bacterial pathogens involved in periprosthetic infection by antibiotic-loaded calcium sulfate beads in vitro. Biomed Mater 2016; 12:015002 [View Article] [PubMed]
    [Google Scholar]
  29. Qin C-H, Zhou C-H, Song H-J, Cheng G-Y, Zhang H-A et al. Infected bone resection plus adjuvant antibiotic-impregnated calcium sulfate versus infected bone resection alone in the treatment of diabetic forefoot osteomyelitis. BMC Musculoskelet Disord 2019; 20:246 [View Article] [PubMed]
    [Google Scholar]
  30. Jogia RM, Modha DE, Nisal K, Berrington R, Kong MF. Use of highly purified synthetic calcium sulfate impregnated with antibiotics for the management of diabetic foot ulcers complicated by osteomyelitis. Diabetes Care 2015; 38:e79–80 [View Article] [PubMed]
    [Google Scholar]
  31. Price BL, Lovering AM, Bowling FL, Dobson CB. Development of a novel collagen wound model to simulate the activity and distribution of antimicrobials in soft tissue during diabetic foot infection. Antimicrob Agents Chemother 2016; 60:6880–6889 [View Article] [PubMed]
    [Google Scholar]
  32. Price BL, Morley R, Bowling FL, Lovering AM, Dobson CB. Susceptibility of monomicrobial or polymicrobial biofilms derived from infected diabetic foot ulcers to topical or systemic antibiotics in vitro. PLoS One 2020; 15:e0228704 [View Article] [PubMed]
    [Google Scholar]
  33. Crowther GS, Callaghan N, Bayliss M, Noel A, Morley R et al. Efficacy of Topical Vancomycin- and Gentamicin-Loaded Calcium Sulfate Beads or Systemic Antibiotics in Eradicating Polymicrobial Biofilms Isolated from Diabetic Foot Infections within an In Vitro Wound Model. Antimicrob Agents Chemother 2021; 65:e02012-20 [View Article] [PubMed]
    [Google Scholar]
  34. NICE guideline [NG19] Diabetic foot problems: prevention and management; 2015 www.nice.org.uk/guidance/ng19/chapter/Recommendations#diabetic-foot-infection
  35. Krause KM, Serio AW, Kane TR, Connolly LE. Aminoglycosides: an overview. Cold Spring Harb Perspect Med 2016; 6:2016 [View Article] [PubMed]
    [Google Scholar]
  36. Sadeghpour Heravi F, Zakrzewski M, Vickery K, G Armstrong D, Hu H. Bacterial diversity of diabetic foot ulcers: current status and future prospectives. J Clin Med 2019; 8:11 [View Article] [PubMed]
    [Google Scholar]
  37. Jneid J, Lavigne JP, La Scola B, Cassir N. The diabetic foot microbiota: A review. Human Microbiome Journal 2017; 5–6:1–6 [View Article]
    [Google Scholar]
  38. Jneid J, Cassir N, Schuldiner S, Jourdan N, Sotto A et al. Exploring the microbiota of diabetic foot infections with culturomics. Front Cell Infect Microbiol 2018; 8:1–8 [View Article] [PubMed]
    [Google Scholar]
  39. Kalan LR, Meisel JS, Loesche MA, Horwinski J, Soaita I et al. Strain- and species-level variation in the microbiome of diabetic wounds is associated with clinical outcomes and therapeutic efficacy. Cell Host Microbe 2019; 25:641–655 [View Article] [PubMed]
    [Google Scholar]
  40. Sloan TJ, Turton JC, Tyson J, Musgrove A, Fleming VM et al. Examining diabetic heel ulcers through an ecological lens: microbial community dynamics associated with healing and infection. J Med Microbiol 2019; 68:230–240 [View Article] [PubMed]
    [Google Scholar]
  41. Renz N, Trampuz A, Zimmerli W. Controversy about the role of rifampin in biofilm infections: is it justified?. Antibiotics (Basel) 2021; 10:165 [View Article] [PubMed]
    [Google Scholar]
  42. Lipsky BA. Diabetic foot infections: Current treatment and delaying the “post-antibiotic era.”. Diabetes Metab Res Rev 2016; 32 Suppl 1:246–253 [View Article] [PubMed]
    [Google Scholar]
  43. Rojo-Molinero E, Macià MD, Oliver A. Social behavior of antibiotic resistant mutants within Pseudomonas aeruginosa biofilm communities. Front Microbiol 2019; 10:570 [View Article] [PubMed]
    [Google Scholar]
  44. Hollenbeck BL, Rice LB. Intrinsic and acquired resistance mechanisms in enterococcus. Virulence 2012; 3:421–433 [View Article] [PubMed]
    [Google Scholar]
  45. Andersson DI, Nicoloff H, Hjort K. Mechanisms and clinical relevance of bacterial heteroresistance. Nat Rev Microbiol 2019; 17:479–496 [View Article] [PubMed]
    [Google Scholar]
  46. Dusane DH, Brooks JR, Sindeldecker D, Peters CW, Li A et al. Complete killing of agar lawn biofilms by systematic spacing of antibiotic-loaded calcium sulfate beads. Materials (Basel) 2019; 12:E4052 [View Article] [PubMed]
    [Google Scholar]
  47. Dusane DH, Diamond SM, Knecht CS, Farrar NR, Peters CW et al. Effects of loading concentration, blood and synovial fluid on antibiotic release and anti-biofilm activity of bone cement beads. J Control Release 2017; 248:24–32 [View Article] [PubMed]
    [Google Scholar]
  48. Kallala R, Haddad FS. Hypercalcaemia following the use of antibiotic-eluting absorbable calcium sulfate beads in revision arthroplasty for infection. Bone Joint J 2015; 97-B:1237–1241 [View Article] [PubMed]
    [Google Scholar]
  49. Oliver RA, Lovric V, Yu Y, Christou C, Aiken SS et al. Development of a novel model for the assessment of dead-space management in soft tissue. PLoS One 2015; 10:e0136514 [View Article] [PubMed]
    [Google Scholar]
  50. McConoughey SJ, Howlin RP, Wiseman J, Stoodley P, Calhoun JH. Comparing PMMA and calcium sulfate as carriers for the local delivery of antibiotics to infected surgical sites. J Biomed Mater Res B Appl Biomater 2015; 103:870–877 [View Article] [PubMed]
    [Google Scholar]
  51. Roberts R, McConoughey SJ, Calhoun JH. Size and composition of synthetic calcium sulfate beads influence dissolution and elution rates in vitro. J Biomed Mater Res B Appl Biomater 2014; 102:667–673 [View Article] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001517
Loading
/content/journal/jmm/10.1099/jmm.0.001517
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error